Patents Assigned to Guangzhou Shenglu Biotech Limited Company
  • Patent number: 10544203
    Abstract: Provided are wild-type, S252W mutant-type, and P253R mutant-type FGFR2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an Fc segment. Also provided are applications of the proteins and a composition comprising the proteins in treating eczema, acne, psoriasis, skin allergy, seborrheic dermatitis, or seborrheic alopecia.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: January 28, 2020
    Assignee: Guangzhou Shenglu Biotech Limited Company
    Inventors: Ju Wang, Yi Wang
  • Publication number: 20170152299
    Abstract: Provided are wild-type, S252W mutant-type, and P253R mutant-type FGFR2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an Fc segment. Also provided are applications of the proteins and a composition comprising the proteins in treating eczema, acne, psoriasis, skin allergy, seborrheic dermatitis, or seborrheic alopecia.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 1, 2017
    Applicant: Guangzhou Shenglu Biotech Limited Company
    Inventors: Ju Wang, Yi Wang